Korean J Dermatol.  2013 Apr;51(4):276-279.

Livedoid Vasculopathy with Hyperhomocysteinemia due to MTHFR Mutation

Affiliations
  • 1Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, Korea.
  • 2Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea. choieh@yonsei.ac.kr

Abstract

Livedoid vasculopathy is a hyalinizing vascular disease characterized by thrombosis and ulceration of the lower extremities. It can be caused by an alteration in control of coagulation with the formation of thrombi within dermal blood vessels. We report a case of livedoid vasculopathy with hyperhomocysteinemia due to MTHFR mutation, which is treated by folic acid and which also showed very unusual clinical manifestations. A 38-year-old male visited the department of dermatology with a 1 year history of purplish-brown purpura with punched-out ulcers on both lower legs. He had a history of homocysteinemia due to methylene tetrahydrofolate reductase (MTHFR) mutation. The histopathologic findings of the lesional skin revealed dense superficial and deep perivascular and perifollicular infiltrates of lymphocytes and fibrin deposition within the vessels in the dermis. On the basis of clinical and pathological findings, livedoid vasculopathy with hyperhomocysteinemia due to MTHFR mutation was diagnosed and improved by the treatment of 1 mg of folic acid daily.

Keyword

Folic acid; Homocysteinemia; Livedoid vasculopathy; Methylene tetrahydrofolate reductase (MTHFR) mutation

MeSH Terms

Blood Vessels
Dermatology
Dermis
Fibrin
Folic Acid
Humans
Hyalin
Hyperhomocysteinemia
Leg
Lower Extremity
Lymphocytes
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Purpura
Skin
Tetrahydrofolates
Thrombosis
Ulcer
Vascular Diseases
Fibrin
Folic Acid
Hyperhomocysteinemia
Methylenetetrahydrofolate Reductase (NADPH2)
Tetrahydrofolates
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr